2,6-Bis((S)-4-methyl-4,5-dihydrooxazol-2-yl)pyridine

Catalog No. :
ACMKNR628
CAS No. :
189014-95-7
Molecular Formula :
C13H15N3O2
Molecular Weight :
245.28

IUPAC Name:2,6-bis((S)-4-methyl-4,5-dihydrooxazol-2-yl)pyridine

2,6-Bis((S)-4-methyl-4,5-dihydrooxazol-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$50.00Login to see priceIn stockInquiry
5g97%$180.00Login to see priceIn stockInquiry
25g97%$659.00Login to see priceIn stockInquiry
100g97%$2360.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Bis((S)-4-methyl-4,5-dihydrooxazol-2-yl)pyridine
IUPAC Name2,6-bis((S)-4-methyl-4,5-dihydrooxazol-2-yl)pyridine
MDL No.MFCD31706427
Molecular FormulaC13H15N3O2
Molecular Weight245.28
SMILESC[C@@H]1N=C(C2=CC=CC(C3=N[C@@H](C)CO3)=N2)OC1
InChI KeyUHXIDHCQNRFIHV-IUCAKERBSA-N
Synonym2,6-bis[(4S)-4,5-dihydro-4-methyl-2-oxazolyl]-Pyridine;2,6-Bis((S)-4-methyl-4,5-dihydrooxazol-2-yl)pyridine;Pyridine, 2,6-bis[(4S)-4,5-dihydro-4-methyl-2-oxazolyl]-;(S,S)-Me-Pybox
CAS No.189014-95-7
PubChem CID24897122

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACMKNR628 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMKNR628 route product structure diagram
    ACMKNR628189014-95-7 In Stock
Inquiry

2. ACMKNR628 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMKNR628 route product structure diagram
    ACMKNR628189014-95-7 In Stock
Inquiry

Comments (0)